David Yoder

Senior Manager of Product Strategy • Aldevron

David Yoder, Ph.D., is a Senior Manager of Product Strategy at Aldevron’s Madison, Wisconsin, facility, with a focus on CRISPR products and services. With a doctorate in Molecular Biology from the University of North Texas, David manages a portfolio of cutting-edge CRISPR technology to help scientists rapidly advance cell and gene therapies by providing high-tech tools to generate engineered cells. He has a broad molecular background with prior work at Promega, Thermo Fisher, and Synthego.

Also Speaking

Mark Roache

Vice President, Cell and Gene Therapies • Quality Executive Partners / Virtuosi

Paolo Siciliano

Cell & Gene Expert • PA Consulting

Jason B. Litten

Chief Medical Officer • Chimeric Therapeutics

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.